Puerarin: A High-Purity C-Glycosyl Isoflavone from Kudzu Root
Introduction
Puerarin (8-β-D-glucopyranosyl-4′,7-dihydroxyisoflavone; CAS 3681-99-0) is a naturally occurring C-glycosyl isoflavone and the principal bioactive constituent of kudzu root (Pueraria lobata), known as Gegen in Traditional Chinese Medicine for over two millennia. It is widely documented for cardiovascular protection, alcohol metabolism enhancement, and menopausal support.
Our puerarin is sourced from cultivated (non-wild) kudzu roots grown in the Qinling and Daba Mountains (Shaanxi, Hubei, Sichuan provinces) — the native habitat where isoflavone accumulation is optimal. Roots are harvested at 3–5 years of age, ensuring high puerarin content and ecological sustainability.
Extraction & Purification Technology
We employ a proprietary, green four-stage process:
-
Countercurrent aqueous ethanol extraction (50% ethanol, 60°C) – selectively extracts isoflavones while minimizing starches and pectins.
-
Macroporous resin adsorption (D101/HPD-100) – removes sugars, proteins, and polar impurities.
-
Polyamide column chromatography – uniquely removes daidzin, daidzein, genistin, and other non-target isoflavones, elevating puerarin ratio from ~40% to >85% in a single pass.
-
Recrystallization from aqueous ethanol – yields crystalline puerarin monohydrate (≥99% purity).
No chlorinated solvents are used; solvent recovery exceeds 90%, supporting environmental sustainability.
Product Grades & Purity
Available in multiple purity grades to suit diverse applications:
-
10%–20% – Standardized kudzu root extract (cost-effective bulk)
-
40%–60% – Enriched for dietary supplements
-
80%–90% – High-purity for clinical formulations
-
≥99% – Pharmaceutical-grade for research and drug development
All grades strictly control related isoflavones (daidzin, daidzein, genistin, genistein, glycitin) with total impurities ≤2.0% for high-purity grades and heavy metals ≤10 ppm, fully compliant with USP, EP, and global nutraceutical/pharmaceutical standards.
Unique Advantages
-
Exceptional stability – The C-glycoside bond (carbon–carbon linkage at position 8) makes puerarin resistant to acid hydrolysis and enzymatic degradation, offering superior thermal stability and long shelf life compared to O-glycoside isoflavones (e.g., daidzin, genistin).
-
Optimized activity profile – Our polyamide column technology selectively reduces daidzein (<2%), which has weaker cardiovascular activity and potential mild estrogenic effects, resulting in a puerarin-enriched extract with maximal benefits per milligram.
-
Sustainable sourcing – Cultivated (not wild-harvested) roots ensure consistent quality, no heavy metal or pesticide concerns, and ecological responsibility.
Key Pharmacological Targets
Puerarin exhibits pleiotropic effects through multiple molecular targets:
-
L-type voltage-gated calcium channels (antagonist)
-
Aldose reductase (inhibitor)
-
Aldehyde dehydrogenase-2 (ALDH-2 activator)
-
Estrogen receptors ERα/ERβ (weak agonist)
-
Endothelial nitric oxide synthase (eNOS activator)
-
NF-κB (inhibitor)
Documented Health Benefits
1. Cardiovascular Protection (most extensively documented)
-
Anti-ischemic & anti-anginal – dilates coronary arteries, increases coronary blood flow, reduces angina frequency by 60–80% (clinical data: IV 400–600 mg/day or oral 150–300 mg/day)
-
Anti-arrhythmic – suppresses ventricular premature beats and reperfusion-induced arrhythmias
-
Antiblood-pressure related – reduces SBP 10–15 mmHg, DBP 5–10 mmHg within 4–8 weeks
-
Anti-thrombotic – inhibits platelet aggregation (TXA₂ and P2Y12 pathways) without gastrointestinal bleeding risk
-
Cardioprotection in myocardial infarction – reduces infarct size and improves post-MI remodeling
-
Diabetic cardiovascular complications – inhibits aldose reductase, prevents diabetic cardiomyopathy and retinopathy
-
Activates ALDH-2 by 30–50%, accelerating acetaldehyde conversion to acetate
-
Protects against alcohol-induced fatty liver (reduces ALT/AST)
3. Neuroprotection & Cognitive Health
- Crosses the blood-brain barrier; reduces infarct volume in cerebral ischemia
4. Menopausal Health (SERM-like activity)
-
Reduces hot flashes, night sweats, and sleep disturbances without breast/endometrial stimulation (ERα antagonism, ERβ agonism)
-
Prevents postmenopausal osteoporosis (increases bone mineral density)
5. Metabolic Health
-
Improves insulin sensitivity (AMPK activation), reduces blood glucose and HbA1c
-
Improves lipid profile (↓LDL, ↓TG, ↑HDL)
-
Protects pancreatic β-cells and reduces hepatic steatosis
6. Anti-Inflammatory & Organ Protection
-
Inhibits NF-κB and NLRP3 inflammasome; reduces TNF-α, IL-1β, IL-6
-
Preclinical efficacy in acute lung injury, acute kidney injury, and inflammatory bowel disease
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.







